EXPLOR工程化外泌体治疗急性肾损伤
本文评述Kim等在Kidney International发表的研究,该研究利用光遗传学工程化外泌体技术EXPLOR,将外泌体核因子-κB抑制因子递送至小鼠肾脏缺血再灌注前后,发现可下调肾脏NF-κB信号并改善急性肾损伤,具有科学意义和潜在临床价值。
要点
- EXPLOR技术可工程化外泌体递送NF-κB抑制因子至肾脏。
- 在肾缺血再灌注前后给药均改善小鼠急性肾损伤。
- 外泌体通过下调肾脏NF-κB信号发挥保护作用。
核心结论
- EXPLOR工程化外泌体可下调肾脏NF-κB信号并改善小鼠急性肾损伤。
研究设计与样本
- 评述Kim等发表于Kidney International的研究,使用光遗传学工程化外泌体技术EXPLOR在小鼠肾缺血再灌注前后递送外泌体NF-κB抑制因子。
主要发现
- EXPLOR外泌体在肾缺血再灌注前后给药均下调肾脏NF-κB信号并改善急性肾损伤。
临床怎么用
- 该技术提示外泌体递送NF-κB抑制因子可能成为急性肾损伤的治疗策略,但尚需临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Exosomes are emerging as a novel drug delivery system for the treatment of numerous diseases, including acute kidney injury. In this issue of Kidney International, Kim et al. use a novel optogenetically engineered exosome technology, "EXPLOR," to deliver the exosomal repressor of nuclear factor-κB into mice before and after renal ischemia-reperfusion. They report that these exosomes downregulated renal nuclear factor-κB signaling and ameliorated acute kidney injury. This study deserves attention for its significant scientific and potential clinical value in acute kidney injury.
引用
- Goggins E, Tanaka S. EXPLORing exosomes for the treatment of acute kidney injury. Kidney Int. 2021. PMID: 34420658. doi:10.1016/j.kint.2021.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。